Carson Wealth (CWM LLC)’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDTX
NMC
VCM
Carson Wealth (CWM LLC)'s BDTX Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its Black Diamond Therapeutics (BDTX) stake by 80% in Q1 2026, selling an estimated $692 and leaving 74 shares worth $158. The position accounts for ﹤0.01% of the portfolio, ranked #5549.
Carson Wealth (CWM LLC) first reported a position in BDTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $36K in Q2 2025. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.
- Carson Wealth (CWM LLC) held 74 shares of Black Diamond Therapeutics worth $158 as of Q1 2026.
- Carson Wealth (CWM LLC) sold 291 Black Diamond Therapeutics shares in Q1 2026, an estimated $692.
- Black Diamond Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5549 holding.
- Carson Wealth (CWM LLC) first reported a position in Black Diamond Therapeutics in Q4 2021 and has held it in 18 quarters since.
- Carson Wealth (CWM LLC)'s Black Diamond Therapeutics position peaked at $36K in Q2 2025.
- 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.